Literature DB >> 30783749

Blood pressure circadian rhythm alterations in alpha-synucleinopathies.

Fabrizio Vallelonga1, Cristina Di Stefano2, Aristide Merola3, Alberto Romagnolo4, Gabriele Sobrero2, Valeria Milazzo2, Alessio Burrello5, Jacopo Burrello2, Maurizio Zibetti4, Franco Veglio2, Simona Maule2.   

Abstract

INTRODUCTION: We sought to analyze the blood pressure (BP) circadian rhythm in Parkinson's disease (PD), multiple system atrophy (MSA), and pure autonomic failure (PAF) and to evaluate the effect of vasoactive and dopaminergic medications on BP fluctuations during activities of daily living.
METHODS: We analyzed data from patients with PD (n = 72), MSA (n = 18), and PAF (n = 17) evaluated with 24-h ambulatory BP monitoring (ABPM) at our Center between 1996 and 2015. Comparisons between groups were performed according to (a) clinical diagnosis and (b) pharmacological treatment. ABPM parameters included 24-h BP variability, BP load, nocturnal dipping, and awakening hypotension.
RESULTS: The average BP was 121 ± 14/72 ± 8 mmHg during daytime and 133 ± 20/76 ± 13 mmHg during nighttime (p < 0.01), with BP load of 24 ± 22/15 ± 16% (daytime) vs. 61 ± 36/52 ± 36% (nighttime) (p < 0.01). In-office BP measurements were consistent with OH in 95 patients (89%) and SH in 63 (59%). ABPM demonstrated increased BP variability in 67 patients (63%), awakening hypotension in 63 (59%), "reverse dipping" in 85 (79.4%), "reduced dipping" in 13 (12.1%), and "normal dipping" in 9 (8.4%). No differences were observed between PD, MSA, and PAF, but a sub-analysis of PD patients revealed two distinct patterns of BP alterations. No significant differences were observed in relation to the use of vasoactive or dopaminergic medications.
CONCLUSION: Regardless of the neurological diagnosis and pharmacological treatment, patients with alpha-synucleinopathies showed a BP circadian rhythm characterized by increased BP variability, reverse dipping, increased BP load, and awakening hypotension.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Blood pressure variability; Cardiovascular autonomic neuropathy; Orthostatic hypotension.; Reverse dipping

Mesh:

Substances:

Year:  2019        PMID: 30783749     DOI: 10.1007/s00415-019-09244-w

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

Review 1.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

Review 2.  Abnormal circadian blood pressure regulation and cognitive impairment in α-synucleinopathies.

Authors:  Ryota Tanaka; Nobutaka Hattori
Journal:  Hypertens Res       Date:  2022-09-20       Impact factor: 5.528

3.  24-hour ambulatory blood pressure alterations in patients with Parkinson's disease.

Authors:  Liwei Shen; Xiaoli Yang; Wenmei Lu; Weijie Chen; Xiaofei Ye; Danhong Wu
Journal:  Brain Behav       Date:  2021-11-28       Impact factor: 2.708

4.  Reply.

Authors:  Jiunn-Tyng Yeh; Tzu-Jung Chiu; Hao-Min Cheng
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-11       Impact factor: 3.738

5.  Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure?

Authors:  Fabrizio Vallelonga; G Sobrero; A Romagnolo; S Maule; A Merola; M Valente; M Giudici; C Di Stefano; V Milazzo; J Burrello; A Burrello; F Veglio
Journal:  J Neurol       Date:  2022-02-22       Impact factor: 6.682

6.  Kinematic but not clinical measures predict falls in Parkinson-related orthostatic hypotension.

Authors:  Andrea Sturchio; Alok K Dwivedi; Luca Marsili; Aaron Hadley; Gabriele Sobrero; Dustin Heldman; Simona Maule; Leonardo Lopiano; Cristoforo Comi; Maurizio Versino; Alberto J Espay; Aristide Merola
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

Review 7.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.